SHELTON, CT / ACCESS Newswire / July 8, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...

Multiple new clinical trials are underway to evaluate if various treatments will prove effective against the Bundibugyo Ebola ...

The strain of the virus that's responsible for the current outbreak has no specific treatments or preventive measures. Three ...

SHELTON, CT / ACCESS Newswire / June 29, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...

Households exposed to COVID-19 now have an oral drug specifically cleared to prevent infection after contact with a sick ...

Another problem: Most approved antiviral drugs target a protein, or a patch of it, that may be unique to a single viral species. Other species, and even other strains—not to mention other viral ...

A single drug has been found to inhibit a range of common viruses in lab studies, including coronaviruses, respiratory syncytial virus (RSV), norovirus, and influenza and hepatitis viruses. It will be ...

Q. I’m immunocompromised and take medication for high blood pressure, irregular heartbeat and cholesterol. I tested positive for COVID-19 and the flu while traveling to California. Probably the plane ...

Cryo-EM images show drugs bound to herpes simplex virus protein at nearly atomic detail, while optical tweezer experiments show how the drug-bound protein behaves in real time. Harvard Medical School ...

Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works. The discovery sheds light on an important tool for fighting drug-resistant ...

Pocapavir, the investigational antiviral drug studied, can allow susceptible polioviruses to sensitize resistant ones. Although this strategy seemed to work in previous lab culture studies of the ...

Efforts to innovate in the fight against influenza include universal influenza vaccines — none successful so far. Merck is aiming for universality with a drug, not a vaccine, via the $9.2 billion ...